Results from the Phase 2/3 EASED Trial Demonstrate an Increase of Approximately Three Hours in
ON Time Without Troublesome Dyskinesia for Patients Taking ADS-5102 Compared to Placebo

September 24, 2013 – PatientSafe Solutions, a leader in point-of-care patient safety clinical
workflow applications, today announced that it has closed a strategic investment from EDBI,
the investment arm of the Singapore Economic Development Board, bringing its total Series
C funding to $27 million.

SUNNYVALE, Calif. and SINGAPORE—September 9, 2013 – Enlighted Inc.,
a leader in solutions for improving the effectiveness and value of commercial
buildings and real estate worldwide, today announced a strategic partnership
with EDBI, a leading investment firm headquartered in Singapore, to bring its
advanced energy efficiency solutions to Singapore and other Asian markets.

Singapore, 22nd August 2013 – MerLion Pharmaceuticals (MerLion) announced today that
the U.S. Food and Drug Administration (FDA) has designated finafloxacin for oral and
intravenous (iv) use as a Qualified Infectious Disease Product (QIDP) and for Fast Track
development for the treatment of complicated urinary tract infections (cUTI) including
pyelonephritis, complicated intra-abdominal infections (cIAI) and acute bacterial skin and
skin structure infections (ABSSSI)

Ivantis, developer of the novel Hydrus™ Microstent device designed to lower eye
pressure for glaucoma patients, announced today that it secured an additional $5
MM in the second close of its Series B financing.

MOUNTAIN VIEW, CA – July 16, 2013 – Appcelerator®, the leading mobile
enterprise platform company, today announced it has raised $12.1 million in new
capital to continue aggressively enabling major enterprises to create, deliver and
analyze their entire mobile application portfolio on the Appcelerator Platform.

ABBOTT PARK, Ill., July 15, 2013 – Abbott today announced it has entered into an
agreement to purchase OptiMedica Corporation, a privately held, Silicon Valley-based
ophthalmic device company

Please describe the background to the establishment of goBalto

Unique Business Model Implements Independent, Wholly Owned Asset Discovery
and Development Company (ADDCo) Subsidiaries for Target Programs

NEW YORK–(BUSINESS WIRE [1])–Tremor Video, Inc. (NYSE: TRMR), a leading provider of technology-driven video
advertising solutions, today announced it has closed its previously announced initial public offering of 7,500,000 shares of
common stock at a price to the public of $10.00 per share